Scholar Rock Holding Corporation (SRRK) Fair Value 2026

SRRK · Biotechnology ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.5 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (21/100)

Quick Summary — As of 2026-08-28, Scholar Rock Holding Corporation (SRRK) trades at $57.80. QOC: 5.5/10. Value Trap Risk: 21/100 (SAFE). 0/13 models active.

Key Facts

Ticker
SRRK
Price
$57.80
Quality Score
5.5/10
Value Trap Risk
21/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give SRRK?

0 Intrinsic Value Models vs. Current Price ($57.80)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Scholar Rock Holding Corporation (SRRK) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Scholar Rock Holding Corporation currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About SRRK?

0 of 13 models are currently active for SRRK. See which stocks rank higher →

How Does SRRK Rank in Biotechnology?

Among 625 Biotechnology stocks, SRRK ranks #218 by Quality of Company score. CirclFi's QOC score of 5.5/10 evaluates 32 fundamental signals. A score of 5.5 reflects mixed fundamentals.

See all Most Undervalued Biotechnology Stocks →

Scholar Rock Holding Corporation's positioning within the Biotechnology segment means that market exclusivity window plays an outsized role in fundamental analysis. The sector's unique characteristics — including gene therapy and cell therapy innovation — shape both the opportunity set and risk profile.

Is SRRK a Value Trap?

CirclFi's Value Trap algorithm assigns SRRK a score of 21/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Scholar Rock Holding Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Scholar Rock Holding Corporation earns a quality score of 5.5/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SRRK valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Scholar Rock Holding Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

11 related Biotechnology stocks with 13-model coverage

GNLXGenelux CorporationQOC 5.5IPHAInnate Pharma S.A.QOC 5.5ABVXABIVAX Société AnonymeQOC 5.5CNTBConnect Biopharma Holdings LimitedQOC 5.5LENZLENZ Therapeutics, Inc.QOC 5.5CAPRCapricor Therapeutics, Inc.QOC 5.4CNSYCerenome, Inc.QOC 4.8BIXTBioxytran, Inc.QOC 4.1QTTBQ32 Bio Inc.QOC 6.8EXELExelixis, Inc.QOC 9.6INCYIncyte CorporationQOC 9.5

Read investment analysis: GNLX · IPHA · ABVX · CNTB · LENZ · CAPR · CNSY · BIXT · QTTB · EXEL · INCY

Which Other Stocks Have a Similar Quality Score to SRRK?

7 companies across all industries closest to SRRK’s Quality of Company score of 5.5/10.

AISPAirship AI Holdings, Inc.QOC 5.5HPPHudson Pacific Properties, Inc.QOC 5.5MYNDMynd.ai, Inc.QOC 5.5FCBMFirst Carolina Financial Services, Inc.QOC 5.5BTOCArmlogi Holding Corp.QOC 5.5VMARVision Marine Technologies Inc.QOC 5.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: AISP · HPP · MYND · FCBM · BTOC · VMAR · NVDA

Where Does SRRK Sit in CirclFi's Biotechnology Rankings?

SRRK is ranked against every other Biotechnology stock CirclFi covers in each of these screens.

See all Biotechnology stocks ranked →

What Else Do Investors Ask About Scholar Rock Holding Corporation’s Valuation?

What is Scholar Rock Holding Corporation's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Scholar Rock Holding Corporation (SRRK). The Quality of Company score is 5.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SRRK overvalued or undervalued right now?

At $57.80, 0 of 0 active models suggest SRRK may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Scholar Rock Holding Corporation's business model in Biotechnology.

What does a Quality of Company score of 5.5 mean for SRRK?

Scholar Rock Holding Corporation's QOC of 5.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on SRRK?

CirclFi analyzes SRRK with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is SRRK a value trap in 2026?

Scholar Rock Holding Corporation's Value Trap score is 21/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Scholar Rock Holding Corporation (SRRK) a Quality of Company score of 5.5/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/SRRK/ · Methodology
Primary sources for this SRRK valuation
  • Financial statements: Scholar Rock Holding Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0001727196) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SRRK as of ; valuations recomputed .